ANXA2 and glioblastoma: To definitely assess the inhibitory effects exerted by ANXA2 blockade on the dissemination of GBM cells, we analyzed the impact of ANXA2 antibody treatment in vivo on GBM primary cells (EGFP expressing HuTuP13 cells) xeno-transplanted in the chick embryo chorioallantoic membrane (CAM).